Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Gsk Plc (GSK.L)

GSK Licenses Halozyme's ENHANZE Drug Delivery Technology 5/7/2026 9:31:00 AM

GSK Q1 Core Profit Rises; Affirms 2026 Guidance 4/29/2026 2:35:46 AM

GSK Q1 Total EPS 43.2p; Core EPS 46.5p 4/29/2026 2:05:04 AM

FDA Accepts Priority Review And Grants BT Designation For Bepirovirsen In Chronic Hepatitis B 4/28/2026 7:31:15 AM

FDA Grants Priority Review And Breakthrough Therapy Designation For Bepirovirsen In C. Hepatitis 4/28/2026 7:22:37 AM

GSK: NDA For Bepirovirsen Granted Priority Review 4/28/2026 2:38:18 AM

GSK: FDA Grants Priority Review To Bepirovirsen NDA For Chronic Hepatitis B 4/28/2026 2:24:35 AM

Amended: GSK's Tesaro Provides Update On Anticipatory Breach Claim In AnaptysBio Litigation 4/27/2026 2:23:06 AM

GSK's TESARO Wins Motion To Dismiss Anticipatory Breach Claim Over Dostarlimab License Agreement 4/27/2026 2:06:40 AM

GSK's Blenrep Combo Wins China Approval For Multiple Myeloma 4/20/2026 2:31:19 AM

GSK Says NMPA Of China Approves Blenrep For Treatment Of 2L+ Relapsed/refractory Multiple Myeloma 4/20/2026 2:08:47 AM

GSK Announces Positive Results From Phase 1 BEHOLD-1 Trial For Mocertatug Rezetecan In Gynaecological Cancers 4/13/2026 2:06:18 AM

GSK Announces Positive Phase I Results For Mo-Rez In Ovarian And Endometrial Cancer 4/12/2026 9:46:18 PM

Weekly Buzz: MGNX Resumes LINNET; GSK Wins China Nod; FDA Okays Waters; NBIX Snaps Up SLNO 4/10/2026 10:00:43 AM

GSK Announces Approval Of Exdensur In China 4/8/2026 2:13:21 AM

GSK Says Exdensur Approved In China For Treatment Of Chronic Rhinosinusitis With Nasal Polyps 4/8/2026 2:02:13 AM

Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS 4/3/2026 5:10:06 AM

GSK Announces Completion Of Pfizer's Exit Of Its Investment In ViiV Healthcare 4/1/2026 2:35:40 AM

GSK, Pfizer And Shionogi Complete Changes To ViiV Healthcare Shareholding 4/1/2026 2:07:06 AM

Samsung Biologics Closes Acquisition Of GSK's Manufacturing Facility In Rockville, Maryland 3/31/2026 10:05:06 AM

- 1
- 2
- 3
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap